Alto Neuroscience ANRO Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's total liabilities?
- Alto Neuroscience (ANRO) reported total liabilities of $32.89M in Q1 2026.
- How has Alto Neuroscience's total liabilities changed year-over-year?
- Alto Neuroscience's total liabilities increased by 0.2% year-over-year, from $32.82M to $32.89M.
- What is the long-term trend for Alto Neuroscience's total liabilities?
- Over 2 years (2023 to 2025), Alto Neuroscience's total liabilities has grown at a 41.2% compound annual growth rate (CAGR), from $16.82M to $33.55M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.